Anmelden Kostenlos registrieren

180 Life Sciences Bargeld je Aktie

Was ist das Bargeld je Aktie von 180 Life Sciences?

Bargeld je Aktie von 180 Life Sciences Corp. ist 0.30

Was ist die Definition von Bargeld je Aktie?

Barmittel pro Aktie ist der Kassenbestand eines Unternehmens, geteilt durch die ausstehenden Aktien des Unternehmens.

Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.

When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.

Bargeld je Aktie von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu 180 Life Sciences

Was macht 180 Life Sciences?

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Unternehmen mit bargeld je aktie ähnlich 180 Life Sciences